期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 245, 期 1-2, 页码 137-140出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2005.08.022
关键词
multiple sclerosis; interferon beta; cognitive function; clinical trial
Cognitive impairment in multiple sclerosis is frequent, but the effect of immunomodulating drugs and mainly interferon beta (IFNO) on the neuropsychological aspects of the disease has not been fully studied. The data that we have are not conclusive. This paper reviews the effect of IFN beta on cognition in the different clinical forms of the disease and the future directions of clinical trials. (c) 2006 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据